Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of COX-2 inhibition

The invention relates to the use of maslinic acid or natural, synthetic or semi-synthetic maslinic-rich mixtures or of a composition containing said acid for the treatment of pathological processes associated with COX-2 activation, intended, inter alia, for the symptomatic and/or regenerative treatm...

Full description

Saved in:
Bibliographic Details
Main Authors PRADOS OSUNA JOSE, GARCIA-GRANADOS LOPEZ DE HIERRO ANDRES, PARRA SANCHEZ ANDRES, MARTINEZ RODRIGUEZ ANTONIO
Format Patent
LanguageChinese
English
Published 13.04.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the use of maslinic acid or natural, synthetic or semi-synthetic maslinic-rich mixtures or of a composition containing said acid for the treatment of pathological processes associated with COX-2 activation, intended, inter alia, for the symptomatic and/or regenerative treatment of arthrosis, rheumatoid arthritis, fibromyalgia, sciatica and other articular disorders that are difficult to diagnose. The invention also relates to the topical administration thereof.
Bibliography:Application Number: CN200980107213